Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
37335 | 61 | 20.8 | 52% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
106 | 3 | LAW//FORDHAM LAW REVIEW//BUSINESS LAWYER | 71924 |
2277 | 2 | JOURNAL OF THE COPYRIGHT SOCIETY OF THE USA//LAW//IIC-INTERNATIONAL REVIEW OF INDUSTRIAL PROPERTY AND COPYRIGHT LAW | 4613 |
37335 | 1 | PATENTING ANALYSIS//THERAPEUTIC INDUSTRY//AMPHIROA CRASSA | 61 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PATENTING ANALYSIS | authKW | 1501756 | 5% | 100% | 3 |
2 | THERAPEUTIC INDUSTRY | authKW | 1501756 | 5% | 100% | 3 |
3 | AMPHIROA CRASSA | authKW | 500585 | 2% | 100% | 1 |
4 | BROMOPHYCOLIDE | authKW | 500585 | 2% | 100% | 1 |
5 | CALLOPHYCUS OPPOSITIFOLIUS | authKW | 500585 | 2% | 100% | 1 |
6 | CALLOPHYCUS SERRATUS | authKW | 500585 | 2% | 100% | 1 |
7 | COMPETIT ANAL PATENT STRATEGIES | address | 500585 | 2% | 100% | 1 |
8 | COMPLETION OF HUMAN GENOME SEQUENCING GENOMICS AND PROTEOMICS | authKW | 500585 | 2% | 100% | 1 |
9 | DRUG CANDIDATE SELECTION | authKW | 500585 | 2% | 100% | 1 |
10 | DRUG DISCOVERY AND THERAPY | authKW | 500585 | 2% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 2064 | 54% | 0% | 33 |
2 | Pharmacology & Pharmacy | 433 | 49% | 0% | 30 |
3 | Information Science & Library Science | 313 | 11% | 0% | 7 |
4 | Multidisciplinary Sciences | 86 | 7% | 0% | 4 |
5 | Plant Sciences | 22 | 10% | 0% | 6 |
6 | Chemistry, Organic | 21 | 10% | 0% | 6 |
7 | Integrative & Complementary Medicine | 9 | 2% | 0% | 1 |
8 | Biotechnology & Applied Microbiology | 9 | 7% | 0% | 4 |
9 | Planning & Development | 7 | 2% | 0% | 1 |
10 | Management | 2 | 2% | 0% | 1 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | COMPETIT ANAL PATENT STRATEGIES | 500585 | 2% | 100% | 1 |
2 | JOHN E FOGARTY INT | 83429 | 2% | 17% | 1 |
3 | DRUG DISCOVERY CONSERVAT | 71510 | 2% | 14% | 1 |
4 | AQUAT CHEM ECOL | 54114 | 3% | 5% | 2 |
5 | SCI POLICY UNIT | 20019 | 3% | 2% | 2 |
6 | TOWNSVILLE MC | 14721 | 2% | 3% | 1 |
7 | SANGER | 9443 | 2% | 2% | 1 |
8 | BIOENGN BIOSCI | 6738 | 3% | 1% | 2 |
9 | NAT PROD BRANCH | 6672 | 2% | 1% | 1 |
10 | CELL BIOL NEUROSCI | 5930 | 10% | 0% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | EXPERT OPINION ON THERAPEUTIC PATENTS | 119184 | 38% | 1% | 23 |
2 | SCIENTIST | 10105 | 11% | 0% | 7 |
3 | MOLECULAR MEDICINE TODAY | 1510 | 2% | 0% | 1 |
4 | ANNUAL REVIEW OF PHYTOPATHOLOGY | 633 | 2% | 0% | 1 |
5 | GENETIC ENGINEERING NEWS | 571 | 2% | 0% | 1 |
6 | PHYTOCHEMISTRY LETTERS | 400 | 2% | 0% | 1 |
7 | JOURNAL OF NATURAL PRODUCTS | 373 | 5% | 0% | 3 |
8 | ACS MEDICINAL CHEMISTRY LETTERS | 363 | 2% | 0% | 1 |
9 | NATURAL PRODUCT REPORTS | 354 | 2% | 0% | 1 |
10 | BIO-TECHNOLOGY | 348 | 2% | 0% | 1 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TEASDALE, ME , SHEARER, TL , ENGEL, S , ALEXANDER, TS , FAIRCHILD, CR , PRUDHOMME, J , TORRES, M , LE ROCH, K , AALBERSBERG, W , HAY, ME , ET AL (2012) BROMOPHYCOIC ADDS: BIOACTIVE NATURAL PRODUCTS FROM A FIJIAN RED ALGA CALLOPHYCUS SP..JOURNAL OF ORGANIC CHEMISTRY. VOL. 77. ISSUE 18. P. 8000 -8006 | 7 | 33% | 5 |
2 | NORMAN, P , (2002) GLAXOSMITHKLINE PLC: ANALYSIS OF PATENTING 1998-2001.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 12. ISSUE 9. P. 1407-1415 | 3 | 100% | 1 |
3 | THOMAS, SM , BURKE, JF , (1997) GENETICS INSTITUTE: SECRETED PROTEINS GIVE A BUMPY RIDE BUT A PROSPEROUS FUTURE?.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 7. ISSUE 1. P. 9-15 | 3 | 100% | 0 |
4 | LIN, AS , STOUT, EP , PRUDHOMME, J , LE ROCH, K , FAIRCHILD, CR , FRANZBLAU, SG , AALBERSBERG, W , HAY, ME , KUBANEK, J , (2010) BIOACTIVE BROMOPHYCOLIDES R-U FROM THE FIJIAN RED ALGA CALLOPHYCUS SERRATUS.JOURNAL OF NATURAL PRODUCTS. VOL. 73. ISSUE 2. P. 275 -278 | 4 | 44% | 15 |
5 | STOUT, EP , PRUDHOMME, J , LE ROCH, K , FAIRCHILD, CR , FRANZBLAU, SG , AALBERSBERG, W , HAY, ME , KUBANEK, J , (2010) UNUSUAL ANTIMALARIAL MERODITERPENES FROM TROPICAL RED MACROALGAE.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. VOL. 20. ISSUE 19. P. 5662-5665 | 5 | 31% | 8 |
6 | CRAGG, GM , KATZ, F , DAVID, JNA , ROSENTHAL, J , (2012) THE IMPACT OF THE UNITED NATIONS CONVENTION ON BIOLOGICAL DIVERSITY ON NATURAL PRODUCTS RESEARCH.NATURAL PRODUCT REPORTS. VOL. 29. ISSUE 12. P. 1407 -1423 | 6 | 22% | 18 |
7 | NORMAN, P , (2003) MERCK & CO., INC.: ANALYSIS OF PATENTING 1998-2002.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 13. ISSUE 7. P. 1037-1044 | 4 | 44% | 0 |
8 | ADAMS, S , (1999) SMITHKLINE BEECHAM: ANALYSIS OF PATENTING 1995-1998.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 9. ISSUE 9. P. 1173-1183 | 2 | 100% | 2 |
9 | COOK, T , (1999) DEVELOPING TRENDS IN PHARMACEUTICAL PATENT CLAIMS.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 9. ISSUE 5. P. 635-643 | 2 | 100% | 1 |
10 | DUEHOLM, KL , (1998) A STRATEGIC ANALYSIS OF PATENTS COVERING RECEPTORS AND THEIR USE AS RESEARCH TOOLS FILED SINCE 1993 BY THREE MAJOR COMPANIES.EXPERT OPINION ON THERAPEUTIC PATENTS. VOL. 8. ISSUE 7. P. 871-888 | 2 | 100% | 3 |
Classes with closest relation at Level 1 |